Abstract:BackgroundApelin is a peptide ligand of the G-protein-coupled receptor APJ and exhibits anti-diabetes and anti-heart failure activities. However, short serum half-life of the apelin peptide limits its potential clinical applications. This study aimed to develop a long-acting apelin analog. MethodsTo extend apelin's in vivo half-life, we made a recombinant protein by fusing the IgG Fc fragment to apelin-13 (Fc-apelin-13), conducted pharmacokinetics studies in mice, and determined in vitro biological activities in suppressing cyclic adenosine monophosphate and activating extracellular signal-regulated kinase signalling by reporter assays. We investigated the effects of Fc-apelin-13 on food intake, body weight, fasting blood glucose and insulin levels, glucose tolerance test, hepatic steatosis, and cardiac function and fibrosis by subcutaneous administration of Fc-apelin-13 in diet-induced obese mice for 4weeks. ResultsThe estimated half-life of Fc-apelin-13 in blood was approximately 33hours. Reporter assays showed that Fc-apelin-13 was active in suppressing cyclic adenosine monophosphate response element and activating serum response element activities. Four weeks of Fc-apelin-13 treatment in obese mice did not affect food intake and body weight, but resulted in a significant improvement of glucose tolerance, and a decrease in hepatic steatosis and fibrosis, as well as in serum alanine transaminase levels. Moreover, cardiac stroke volume and output were increased and cardiac fibrosis was decreased in the treated mice. ConclusionsFc-apelin-13 fusion protein has an extended in vivo half-life and exerts multiple benefits on obese mice with respect to the improvement of glucose disposal, amelioration of liver steatosis and heart fibrosis, and increase of cardiac output. Hence, Fc-apelin-13 is potentially a therapeutic for obesity-associated disease conditions.

The Role of Apelin in Obesity Treatment by Exercise Training

Myokines: Metabolic Regulation in Obesity and Type 2 Diabetes

Apelin administration ameliorates high fat diet-induced cardiac hypertrophy and contractile dysfunction

Adipose Tissue Adipokines and Lipokines: Functions and Regulatory Mechanism in Skeletal Muscle Development and Homeostasis.

Apelin regulates skeletal muscle adaptation to exercise in a high intensity interval training (HIIT) model.

Apelin Plays A Catabolic Role On Articular Cartilage: In Vivo And In Vitro Studies

Apelin and insulin resistance: Another arrow for the quiver?

Hepatic and Cardiac Beneficial Effects of a Long‐acting Fc‐apelin Fusion Protein in Diet‐induced Obese Mice

Effect of Treadmill Running on Apelin and APJ Expression in Adipose Tissue and Skeletal Muscle in Rats Fed a High-fat Diet.

Apelin Stimulates Glucose Utilization in Normal and Obese Insulin-Resistant Mice

Apelin-36 Modulates Blood Glucose and Body Weight Independently of Canonical APJ Receptor Signaling

Study Progression of Apelin/APJ Signaling and Apela in Different Types of Cancer

Regulation of apelin and its receptor expression in adipose tissues of obesity rats with hypertension and cultured 3T3-L1 adipocytes

Apelin/APJ system: an emerging therapeutic target for respiratory diseases

Correction: Apelin Ameliorates TNF-α-Induced Reduction of Glycogen Synthesis in the Hepatocytes Through G Protein-Coupled Receptor APJ

Apelin decreases lipolysis via G(q), G(i), and AMPK-Dependent Mechanisms

Function of Apelin in Cardiovascular System and Adipoinsular Axis

Expression of Apelin in Obese Rats with Heart Failure

The Role of Chemokines in Obesity and Exercise-Induced Weight Loss

Apelin Alleviates High Fat Diet‐Induced Cardiac Remodeling and Myocardial Contractile Dysfunction: Role of Mirna‐133a

The exerkine apelin reverses age-associated sarcopenia